The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study
Abstract Background The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). Methodology T...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-01-01
|
| Series: | BioPsychoSocial Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13030-020-00202-x |
| _version_ | 1831772639351275520 |
|---|---|
| author | Firoozeh Mostafavi Fereshteh Zamani Alavijeh Arash Salahshouri Behzad Mahaki |
| author_facet | Firoozeh Mostafavi Fereshteh Zamani Alavijeh Arash Salahshouri Behzad Mahaki |
| author_sort | Firoozeh Mostafavi |
| collection | DOAJ |
| description | Abstract Background The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). Methodology This descriptive qualitative study was done in Isfahan, Iran by conducting in-depth unstructured interviews with 23 purposively selected patients with T2D and 10 healthcare providers (HCPs). The participants were interviewed face-to-face between November 2017 and June 2018 at the patient’s home, a Health Care Center, or at the diabetes clinic. Data analysis was performed using MAXQDA-10 software and the conventional content analysis. Results The analysis of the data led to six categories of perceived psychosocial barriers: 1) fear, concern and distress, 2) exhaustion and burnout, 3) the children’s issues being the priority, 4) poor financial support, 5) communication challenges, and 6) poor work conditions. Conclusions This study identified some of the psychosocial barriers to medication adherence of patients with T2D, which will be of great help to researchers and HCPs in designing and implementing effective interventions to overcome these barriers and change patient self-care behaviors and increase their medication adherence. |
| first_indexed | 2024-12-22T08:21:35Z |
| format | Article |
| id | doaj.art-1ba0d9ab5dce451a90763130692b63d9 |
| institution | Directory Open Access Journal |
| issn | 1751-0759 |
| language | English |
| last_indexed | 2024-12-22T08:21:35Z |
| publishDate | 2021-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BioPsychoSocial Medicine |
| spelling | doaj.art-1ba0d9ab5dce451a90763130692b63d92022-12-21T18:32:44ZengBMCBioPsychoSocial Medicine1751-07592021-01-0115111110.1186/s13030-020-00202-xThe psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative studyFiroozeh Mostafavi0Fereshteh Zamani Alavijeh1Arash Salahshouri2Behzad Mahaki3Department of Health Education and Promotion, School of Health, Isfahan University of Medical SciencesDepartment of Health Education and Promotion, School of Health, Isfahan University of Medical SciencesDepartment of Health Education and Promotion, School of Health, Ahvaz Jundishapur University of Medical SciencesDepartment of Biostatistics, School of Health, Kermanshah University of Medical SciencesAbstract Background The adherence of diabetic patients to their medication regimen is associated with many psychosocial factors that are still unknown. Therefore, the present study aims to identify the psychosocial barriers to medication adherence of patients with type2 diabetes (T2D). Methodology This descriptive qualitative study was done in Isfahan, Iran by conducting in-depth unstructured interviews with 23 purposively selected patients with T2D and 10 healthcare providers (HCPs). The participants were interviewed face-to-face between November 2017 and June 2018 at the patient’s home, a Health Care Center, or at the diabetes clinic. Data analysis was performed using MAXQDA-10 software and the conventional content analysis. Results The analysis of the data led to six categories of perceived psychosocial barriers: 1) fear, concern and distress, 2) exhaustion and burnout, 3) the children’s issues being the priority, 4) poor financial support, 5) communication challenges, and 6) poor work conditions. Conclusions This study identified some of the psychosocial barriers to medication adherence of patients with T2D, which will be of great help to researchers and HCPs in designing and implementing effective interventions to overcome these barriers and change patient self-care behaviors and increase their medication adherence.https://doi.org/10.1186/s13030-020-00202-xMedication adherencePatientsDiabetes mellitusType 2Qualitative researchIran |
| spellingShingle | Firoozeh Mostafavi Fereshteh Zamani Alavijeh Arash Salahshouri Behzad Mahaki The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study BioPsychoSocial Medicine Medication adherence Patients Diabetes mellitus Type 2 Qualitative research Iran |
| title | The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study |
| title_full | The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study |
| title_fullStr | The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study |
| title_full_unstemmed | The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study |
| title_short | The psychosocial barriers to medication adherence of patients with type 2 diabetes: a qualitative study |
| title_sort | psychosocial barriers to medication adherence of patients with type 2 diabetes a qualitative study |
| topic | Medication adherence Patients Diabetes mellitus Type 2 Qualitative research Iran |
| url | https://doi.org/10.1186/s13030-020-00202-x |
| work_keys_str_mv | AT firoozehmostafavi thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT fereshtehzamanialavijeh thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT arashsalahshouri thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT behzadmahaki thepsychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT firoozehmostafavi psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT fereshtehzamanialavijeh psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT arashsalahshouri psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy AT behzadmahaki psychosocialbarrierstomedicationadherenceofpatientswithtype2diabetesaqualitativestudy |